ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.800,37
0,03%
S&P 500
6.040,04
1,10%
US Dollar vs BRL
6,7426
0,13%
Bitcoin
95.377,21
-3,95%
Brent Oil
73,64
0,48%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. PolyPid Ltd (PYPD)

  7. PolyPid Ltd (PYPD) Notícias

PYPD

PolyPid (PYPD)

PolyPid Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PYPD
DataHoraFonteTítuloCódigoCompanhia
12/12/202409:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PYPDPolyPid Ltd
11/12/202409:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
08/11/202418:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PYPDPolyPid Ltd
10/09/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PYPDPolyPid Ltd
30/08/202417:01Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PYPDPolyPid Ltd
12/08/202417:27Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PYPDPolyPid Ltd
06/03/202418:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PYPDPolyPid Ltd
06/03/202418:05Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PYPDPolyPid Ltd
01/03/202414:19Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYPDPolyPid Ltd
18/10/202318:07AllPennyStocks.comNew Collaboration Could Revolutionize Treatment of Chronic Spinal Cord InjuriesNASDAQ:PYPDPolyPid Ltd
22/06/202308:12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PYPDPolyPid Ltd
22/05/202310:54Dow Jones NewsFDA Approves PolyPid's Trial Design for D-PLEXNASDAQ:PYPDPolyPid Ltd
17/05/202312:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PYPDPolyPid Ltd
31/03/202316:55Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PYPDPolyPid Ltd
31/03/202307:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PYPDPolyPid Ltd
24/01/202312:24Dow Jones NewsPolyPid Shares Rise 28% After Positive FDA News for D-PLEXNASDAQ:PYPDPolyPid Ltd
12/12/202211:50TipRanksAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
09/11/202216:45TipRanksPolyPid (PYPD) Gets a Buy from JMP SecuritiesNASDAQ:PYPDPolyPid Ltd
28/09/202214:35TipRanksJMP Securities Sticks to Its Buy Rating for PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
02/09/202213:15TipRanksJMP Securities Remains a Buy on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
11/08/202212:06TipRanksAnalysts’ Top Healthcare Picks: PolyPid (PYPD), Nuvalent (NUVL)NASDAQ:PYPDPolyPid Ltd
10/08/202212:15TipRanksJMP Securities Keeps Their Buy Rating on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
24/06/202210:29TipRanksBMO Capital Thinks PolyPid’s Stock is Going to RecoverNASDAQ:PYPDPolyPid Ltd
23/06/202215:25TipRanksJMP Securities Thinks PolyPid’s Stock is Going to RecoverNASDAQ:PYPDPolyPid Ltd
23/05/202212:25TipRanksAnalysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Nektar Therapeutics (NKTR)NASDAQ:PYPDPolyPid Ltd
12/05/202209:51TipRanksBMO Capital Keeps a Buy Rating on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
11/05/202213:49TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Agenus (AGEN), Intercept Pharma (ICPT) and PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
24/02/202215:18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PYPDPolyPid Ltd
04/01/202203:53TipRanksPolypid Names New CEO; Shares Jump 6.3%NASDAQ:PYPDPolyPid Ltd
16/12/202102:25TipRanksPolyPid (PYPD) Gets a Buy Rating from JMP SecuritiesNASDAQ:PYPDPolyPid Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:PYPD

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
FICT3
Fictor Alimentos ON
BOV
AZEV4
AZEVEDO PN
BOV
AZUL4
AZUL PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados